You are here:Home-Chemical Inhibitors & Agonists-Apoptosis-IAP-Birinapant
Birinapant

Chemical Structure : Birinapant

CAS No.: 1260251-31-7

Birinapant (TL32711, TL 32711)

Catalog No.: PC-21402Not For Human Use, Lab Use Only.

Birinapant (TL32711) is a bivalent, selective small molecule SMAC mimetic, binds with high affinity to multiple members of the IAP family with Kd of 45 nM and <1 nM for XIAP and cIAP1 respectively.

Packing Price Stock Quantity
5 mg $138 In stock
10 mg $208 In stock
25 mg $388 In stock
50 mg $558 In stock
100 mg Get quote

Bulk size, bulk discount!

E-mail: sales@probechem.com

Tech Support: tech@probechem.com

Purity & Documentation Purity: >98% (HPLC) Select Batch:

Biological Activity

Birinapant (TL32711) is a bivalent, selective small molecule SMAC mimetic, binds with high affinity to multiple members of the IAP family with Kd of 45 nM and <1 nM for XIAP and cIAP1 respectively.
Birinapant (TL32711) binds to the BIR3 domains of cIAP1, cIAP2, XIAP, and the BIR domain of ML-IAP in vitro.
v specifically targets cIAP1 and cIAP2 for degradation, resulting in a switch in TNFR signaling; activation of TNFR upon binding of TNF-α in the presence of cIAP1 and cIAP2 leads to NF-κB activation and increased cell proliferation.
Birinapant (TL32711) in combination with TNF-α elicites anti-melanoma effect in a parental and BRAF inhibitor resistant cell line.
Birinapant (TL32711) preferentially targets the TRAF2-associated cIAP1 and cIAP2 with subsequent inhibition of TNF-induced NF-κB activation.
Birinapant (TL32711) inhibits umor growth in multiple primary patient-derived xenotransplant models.

Physicochemical Properties

M.Wt 806.96
Formula C42H56F2N8O6
Appearance Solid
CAS No.
Storage
Solide Powder
-20°C 12 Months; 4°C 6 Months
In Solvent
-80°C 6 Months; -20°C 6 Months
Shipping
Solubility

10 mM in DMSO

Chemical Name/SMILES

FC1=CC=C(C(C[C@H]2N(C[C@H](C2)O)C([C@H](CC)NC([C@H](C)NC)=O)=O)=C(C3=C(C4=CC=C(F)C=C4N3)C[C@H]5N(C[C@H](C5)O)C([C@H](CC)NC([C@H](C)NC)=O)=O)N6)C6=C1

References

1. Benetatos CA, et al. Mol Cancer Ther. 2014 Apr;13(4):867-79.

2. Krepler C, et al. Clin Cancer Res. 2013 Apr 1;19(7):1784-94.

Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright

Contact Us sales@probechem.com

Bulk Inquiry

* Indicates a Required FieldYour information is safe with us.

  • *Product name:
  • *Applicant name:
  • *Email address:
  • *Organization name:
  • *Requested quantity:
  • *Country:
  • *Additional Information:

Get Quote

* Indicates a Required FieldYour information is safe with us.

  • *Product name:
  • *Applicant name:
  • *Email address:
  • *Organization name:
  • *Requested quantity:
  • *Country:
  • Additional Information: